HCA Holdings Inc. buy Royal Bank of Canada
Start price
31.01.24
/
50%
€282.20
Target price
31.01.25
€296.76
Performance (%)
1.74%
Price
26.04.24
€286.50
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 1.74%. Dividends of €0.61 are taken into consideration when calculating the performance. This prediction currently runs until 31.01.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
HCA Holdings Inc. | 0.000% | 0.000% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread HCA Holdings Inc. diskutieren
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Royal Bank of Canada from $308.00 to $322.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for HCA Holdings Inc.
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€213.30
25.10.23
25.10.23
€268.66
25.10.24
25.10.24
34.86%
26.04.24
26.04.24
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€244.70
13.09.23
13.09.23
€293.45
13.09.24
13.09.24
17.79%
26.04.24
26.04.24